![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Hovione Pharmascience Limited Taipa Mo, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ivermectin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1998-138 - Rev 05
This Chemical Type CEP, issued on February 28, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1336 associated with this CEP further emphasizes